Cargando…
Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats
Chalcone-1-deoxynojirimycin heterozygote (DC-5), a novel compound which was designed and synthesized in our laboratory for diabetes treatment, showed an extremely strong in vitro inhibitory activity on α-glucosidase in our previous studies. In the current research, its potential in vivo anti-diabeti...
Autores principales: | Xiao, Pin-Jian, Zeng, Jia-Cheng, Lin, Ping, Tang, Dao-Bang, Yuan, En, Tu, Yong-Gang, Zhang, Qing-Feng, Chen, Ji-Guang, Peng, Da-Yong, Yin, Zhong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658082/ https://www.ncbi.nlm.nih.gov/pubmed/36364410 http://dx.doi.org/10.3390/molecules27217583 |
Ejemplares similares
-
1-Deoxynojirimycin Alleviates Liver Injury and Improves Hepatic Glucose Metabolism in db/db Mice
por: Liu, Qingpu, et al.
Publicado: (2016) -
Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
por: Lin, Ping, et al.
Publicado: (2020) -
1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin-induced diabetic mice
por: Li, You-Gui, et al.
Publicado: (2013) -
1-Deoxynojirimycin from mulberry leaves changes gut digestion and microbiota composition in geese
por: Hou, Qirui, et al.
Publicado: (2020) -
1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy
por: Zhuang, Qianqian, et al.
Publicado: (2023)